Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator

Hospital of the Westfalische-Wilhelms University of Munster, Department of Cardiology and Angiology, Germany.

OBJECTIVES. This study was conducted to assess the effectiveness of antitachycardia pacing modes and detection algorithms in patients with a new third-generation implantable cardioverter-defibrillator. METHODS. Twenty-three of 42 consecutive patients had coronary artery disease, 14 had dilated cardiomyopathy, 2 had prior valve replacement and 3 had arrhythmogenic right ventricular dysplasia. The mean ejection fraction was 41 +/- 14%; there were 31 men (74%) and 11 women, with a mean age of 53 years. On the basis of preoperative and postoperative electrophysiologic studies, in 28 patients antitachycardia pacing was postoperatively programmed randomly as "burst" (66%) or autodecremental "ramp" (34%) stimulation with a first coupling interval of 81% of tachycardia cycle length and up to 8 sequences with 3 to 10 stimuli. RESULTS. During a follow-up interval of 6.3 +/- 2.2 months, 15 patients were treated by antitachycardia pacing for a median of 6 (range 1 to 59) hemodynamically stable ventricular tachycardias (175 +/- 12 beats/min). In 5 patients, 22 ventricular tachycardias (9%) were not terminated by antitachycardia pacing but by cardioversion. Seven (3%) of these episodes accelerated (> 50 ms) during antitachycardia pacing. Syncope did not occur during these episodes. In seven patients initial antitachycardia pacing in cases of supraventricular tachycardias delayed charging and redetection prevented inappropriate discharges. Additional detection algorithms were programmed only after inappropriate therapy. The sudden "onset" and "sustained rate duration" criteria were programmed in three patients and the cycle length "stability" criteria in six patients, respectively. After activation of these detection algorithms only two of the seven patients had further inappropriate device discharges. CONCLUSIONS. Thus, antitachycardia pacing by this implantable cardioverter-defibrillator effectively and appropriately terminated 91% of hemodynamically stable ventricular tachycardias. Inappropriate device discharges were prevented in some patients by antitachycardia pacing and additional detection algorithms.

This article has been cited by other articles:

				G. Boriani, E. Occhetta, S. Cesario, S. Grossi, M. Marconi, G. Speca, P. Silvestri, M. Biffi, M. Bortnik, C. Martignani, et al. Contribution of morphology discrimination algorithm for improving rhythm discrimination in slow and fast ventricular tachycardia zones in dual-chamber implantable cardioverter-defibrillators Europace, August 1, 2008; 10(8): 918 - 925. [Abstract] [Full Text] [PDF]

				A. K. Gehi, D. Mehta, and J. A. Gomes Evaluation and Management of Patients After Implantable Cardioverter-Defibrillator Shock JAMA, December 20, 2006; 296(23): 2839 - 2847. [Abstract] [Full Text] [PDF]

				J M Morgan The MADIT II and COMPANION studies: will they affect uptake of device treatment? Heart, March 1, 2004; 90(3): 243 - 245. [Full Text] [PDF]

				L. B. Mitchell, E. A. Pineda, J. L. Titus, P. M. Bartosch, and D. G. Benditt Sudden death in patients with implantable cardioverter defibrillators: The importance of post-shock electromechanical dissociation J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1323 - 1328. [Abstract] [Full Text] [PDF]

				M. S. Wathen, M. O. Sweeney, P. J. DeGroot, A. J. Stark, J. L. Koehler, M. B. Chisner, C. Machado, and W. O. Adkisson Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease Circulation, August 14, 2001; 104(7): 796 - 801. [Abstract] [Full Text] [PDF]

				C.M Pratt, A.J Camm, J.T Bigger Jr, G Breithardt, R.W.F Campbell, A.E Epstein, L.J Kappenberger, K.-H Kuck, S Pocock, S Saksena, et al. Evaluation of antiarrhythmic drug efficacy in patients with an ICD. Unlimited potential or replete with complexity and problems? Eur. Heart J., November 1, 1999; 20(21): 1538 - 1552. [Abstract] [PDF]

				A. Arenal, J. Almendral, J. Villacastin, R. Morris, E. Castellanos, and J. L. Delcan First Postpacing Interval Variability During Right Ventricular Stimulation : A Single Algorithm for the Differential Diagnosis of Regular Tachycardias Circulation, August 18, 1998; 98(7): 671 - 677. [Abstract] [Full Text] [PDF]

				A. Schaumann, F. v. z. Muhlen, B. Herse, B.-D. Gonska, and H. Kreuzer Empirical Versus Tested Antitachycardia Pacing in Implantable Cardioverter Defibrillators : A Prospective Study Including 200 Patients Circulation, January 13, 1998; 97(1): 66 - 74. [Abstract] [Full Text] [PDF]

				G. J. Fahy, E. B. Sgarbossa, P. J. Tchou, and S. L. Pinski Hospital Readmission in Patients Treated With Tiered-Therapy Implantable Defibrillators Circulation, September 15, 1996; 94(6): 1350 - 1356. [Abstract] [Full Text]

				D. P. Zipes and D. Roberts Results of the International Study of the Implantable Pacemaker Cardioverter-Defibrillator : A Comparison of Epicardial and Endocardial Lead Systems Circulation, July 1, 1995; 92(1): 59 - 65. [Abstract] [Full Text]